4//SEC Filing
Kjems Lise Lund 4
Accession 0001437749-22-005029
CIK 0000922247other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 4:42 PM ET
Size
5.0 KB
Accession
0001437749-22-005029
Insider Transaction Report
Form 4
Kjems Lise Lund
Chief Medical Officer
Transactions
- Award
Stock Option (Right to buy)
2022-02-28+31,141→ 31,141 totalExercise: $3.26Exp: 2032-02-28→ Common Stock (31,141 underlying)
Footnotes (1)
- [F1]The option vests over a four year period in equal monthly installments.
Documents
Issuer
Cyclo Therapeutics, Inc.
CIK 0000922247
Entity typeother
Related Parties
1- filerCIK 0001884844
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 4:42 PM ET
- Size
- 5.0 KB